|
|
|
February 06, 2026
|
|
|
|
|
|
|
|
|
The Super Bowl offers a massive, if expensive, window of opportunity for advertisers looking to take advantage of its unrivaled audience reach – a reality that GLP-1 drugs and other healthcare products will harness this weekend. There’s also an outside chance this year might be their last chance to do so, should U.S. health secretary Robert F. Kennedy Jr. get his
way.
However they’re justifying it, pharma brands are spending heavily on the Big Game on NBC and Peacock this year, in contrast with the category’s traditional focus on news and daytime TV over live sports.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PARTNER INSIGHTS FROM NEXXEN
|
|
|
|
|
|
|
|
|
|
|
|
Member exclusive |
|
|
|
|
|
|
|
|
|
PARTNER INSIGHTS FROM QUANTCAST
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PARTNER INSIGHTS FROM NPR
| |